Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab.
Mohamed YI, Lee SS, Demir T, Chamseddine S, Hu ZI, Xiao L, Elsayes K, Morris JS, Wolff RA, Hiatia R, Qayyum A, Rashid A, Duda DG, Yao JC, LaPelusa M, Koay EJ, Mahvash A, Al Azzam A, Dumbrava EE, Hassan M, Amin HM, Kaseb AO.
Mohamed YI, et al. Among authors: yao jc.
Cancer Biomark. 2024 Aug 21. doi: 10.3233/CBM-230431. Online ahead of print.
Cancer Biomark. 2024.
PMID: 39269823